CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy [Phase 1]
Summary
Phase 1 study update reporting on the safety and tolerability of dalfampridine in subjects with cerebral palsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acorda Therapeutics | Conditions: Cerebral Palsy (CP) | Phase 1 | Status: COMPLETED | Results posted: 2014-06-24